Amanote Research
Register
Sign In
ES03.04 Role of Chemotherapy in Mesothelioma With Minimal Bulk Disease
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.029
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
C. Lee
Publisher
Elsevier BV
Related search
Chemotherapy of Malignant Pleural Mesothelioma.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
A Seven-Year Disease-Free Survivor of Malignant Pleural Mesothelioma Treated With Hyperthermia and Chemotherapy: A Case Report
Journal of Medical Case Reports
Medicine
ES03.05 Role of Surgery in T0 Mesothelioma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Benefit of Consolidation Radiotherapy to Initial Disease Bulk in Patients With Advanced Hodgkin's Disease Who Achieved Complete Remission After Standard Chemotherapy
Journal of Blood Medicine
Hematology
IgA Nephropathy With Minimal Change Disease
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
P2.06-30 Association of Histopathological Patterns of Mesothelioma and Response to Treatment With Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PI3K/mTOR Signaling in Mesothelioma Patients Treated With Induction Chemotherapy Followed by Extrapleural Pneumonectomy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA08.02 DREAM - A Phase 2 Trial of Durvalumab With First Line Chemotherapy in Mesothelioma: Final Result
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Adjuvant Bidirectional Chemotherapy With Intraperitoneal Pemetrexed Combined With Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
Gastroenterology Research and Practice
Hepatology
Gastroenterology
